Drugs / INCB019602
last change Jun 2009 re-read 3 minutes ago

INCB019602

Developed for
type 2 diabetes mellitus
Investigated by
Incyte Corporation

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00698789 May 2008 → Feb 2009 type 2 diabetes mellitus Incyte Corporation Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as INCB019602 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00698789 ↗